Decoy Therapeutics Inc. (DCOY) vs NewGenIvf Group Limited (NIVF)
Over the past 3 years, DCOY outperformed NIVF — -87.88% vs -99.74% annualized total return (price plus dividends).
A side-by-side comparison of Decoy Therapeutics Inc. and NewGenIvf Group Limited across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
Total return — DCOY vs NIVF
growth of $100 · dividends reinvested · last 5yMetrics side by side
Did DCOY beat NIVF?
Over the past 3 years, DCOY outperformed NIVF — -87.88% vs -99.74% annualized total return (price plus dividends).
Total return (annualized)
| Metric | DCOY | NIVF |
|---|---|---|
| Total return (1Y) | -96.49% | -99.99% |
| Total return CAGR (3Y) | -87.88% | -99.74% |
| Total return CAGR (5Y) | -86.39% | N/A |
| Total return CAGR (10Y) | -79.17% | N/A |
NIVF is an index fund, so valuation, profitability, and per-company growth metrics don't apply — the head-to-head here is total return (price plus reinvested dividends).
Frequently asked
- Has DCOY beaten NIVF?
- Over the past 3 years, DCOY outperformed NIVF — -87.88% vs -99.74% annualized total return (price plus dividends).
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.